tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Derik De Bruin, 20 are a SELL (17.24%), 47 are a HOLD (40.52%), 49 are a BUY (42.24%).
Analyst Derik De Bruin, currently employed at BAML, carries an average stock price target met ratio of 78.24% that have a potential upside of 15.97% achieved within 129 days.
Derik De Bruin’s has documented 241 price targets and ratings displayed on 30 stocks. The coverage is on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on TXG, 10X Genomics at 18-Jul-2024.
Analyst best performing recommendations are on TLIS (TALIS BIOMEDICAL CORP).
The best stock recommendation documented was for TLIS (TALIS BIOMEDICAL CORP) at 3/16/2022. The price target of $22.5 was fulfilled within 2 days with a profit of $3 (15.38%) receiving and performance score of 76.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
170
$55.51 (48.48%)
170
16 days ago
0/4 (0%)
$56.83 (50.22%)
Buy
175
$60.51 (52.85%)
160
1 months 15 days ago
4/11 (36.36%)
$62.41 (55.43%)
128
Buy
176
$61.51 (53.73%)
2 months 20 days ago
2/6 (33.33%)
$57.02 (47.92%)
29
Sell
80
$-34.49 (-30.12%)
100
6 months 1 days ago
8/9 (88.89%)
$-62.76 (-43.96%)
201
Hold
130
$15.51 (13.55%)
120
6 months 10 days ago
2/16 (12.5%)
$-5.14 (-3.80%)
46
Which stock is Derik De Bruin is most bullish on?
Which stock is Derik De Bruin is most reserved on?
What Year was the first public recommendation made by Derik De Bruin?
